Tasly Pharmaceutical Group Co Ltd
SSE:600535

Watchlist Manager
Tasly Pharmaceutical Group Co Ltd Logo
Tasly Pharmaceutical Group Co Ltd
SSE:600535
Watchlist
Price: 14.46 CNY -1.03% Market Closed
Market Cap: 21.6B CNY
Have any thoughts about
Tasly Pharmaceutical Group Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tasly Pharmaceutical Group Co Ltd

Current Assets 9.8B
Cash & Short-Term Investments 4.8B
Receivables 2.1B
Other Current Assets 2.9B
Non-Current Assets 7.8B
Long-Term Investments 1.9B
PP&E 3.7B
Intangibles 2.1B
Other Non-Current Assets 64.8m
Current Liabilities 3.3B
Accounts Payable 498m
Accrued Liabilities 138.1m
Short-Term Debt 1.9B
Other Current Liabilities 718.3m
Non-Current Liabilities 1.8B
Long-Term Debt 1.3B
Other Non-Current Liabilities 467m

Balance Sheet
Tasly Pharmaceutical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 115
1 081
1 329
1 499
2 691
1 519
1 816
2 104
2 927
3 625
Cash
0
1
0
0
1
1
0
2 104
2 927
3 625
Cash Equivalents
1 115
1 080
1 329
1 499
2 690
1 518
1 816
0
0
0
Short-Term Investments
0
0
0
0
0
59
143
1 487
1 125
301
Total Receivables
5 004
6 578
7 247
10 395
11 606
11 465
5 655
3 845
3 394
2 163
Accounts Receivables
3 559
4 643
4 876
6 748
8 272
8 431
1 872
1 295
896
688
Other Receivables
1 445
1 935
2 371
3 647
3 334
3 034
3 783
2 550
2 498
1 475
Inventory
1 477
1 764
2 012
2 231
2 397
2 547
1 354
1 548
1 532
1 748
Other Current Assets
192
476
587
924
1 126
953
270
265
281
896
Total Current Assets
7 788
9 897
11 176
15 049
17 819
16 543
9 237
9 249
9 259
8 733
PP&E Net
3 516
3 688
3 908
3 961
3 944
4 011
3 889
4 168
3 989
3 812
PP&E Gross
3 516
3 688
3 908
3 961
3 944
4 011
3 889
4 168
3 989
3 812
Accumulated Depreciation
1 190
1 356
1 613
1 914
2 218
2 568
2 744
3 149
3 550
3 898
Intangible Assets
681
840
940
1 046
1 565
1 809
1 646
1 626
1 587
2 027
Goodwill
139
133
138
138
176
143
16
167
16
16
Note Receivable
94
0
0
0
0
0
0
0
0
0
Long-Term Investments
409
530
685
1 054
1 362
1 209
1 535
1 229
1 511
2 054
Other Long-Term Assets
294
324
280
283
306
299
170
103
116
73
Other Assets
139
133
138
138
176
143
16
167
16
16
Total Assets
12 921
N/A
15 413
+19%
17 126
+11%
21 532
+26%
25 172
+17%
24 014
-5%
16 494
-31%
16 542
+0%
16 478
0%
16 714
+1%
Liabilities
Accounts Payable
1 322
1 447
1 857
2 067
2 140
2 112
480
531
592
444
Accrued Liabilities
262
285
391
425
323
244
239
217
248
192
Short-Term Debt
4 755
4 482
5 123
7 753
4 687
3 450
843
387
484
944
Current Portion of Long-Term Debt
57
15
400
404
589
2 189
1 101
399
529
521
Other Current Liabilities
370
358
388
691
777
662
169
322
281
269
Total Current Liabilities
6 767
6 586
8 159
11 340
8 516
8 657
2 832
1 855
2 135
2 370
Long-Term Debt
812
798
400
892
5 156
3 232
1 020
1 116
1 451
1 496
Deferred Income Tax
0
0
0
0
0
4
23
42
23
0
Minority Interest
231
237
243
320
675
732
412
333
265
322
Other Liabilities
274
321
361
326
292
257
235
215
178
159
Total Liabilities
8 083
N/A
7 943
-2%
9 162
+15%
12 877
+41%
14 638
+14%
12 882
-12%
4 521
-65%
3 560
-21%
4 052
+14%
4 346
+7%
Equity
Common Stock
1 033
1 080
1 080
1 080
1 513
1 513
1 513
1 513
1 500
1 500
Retained Earnings
3 562
4 619
5 342
6 113
7 226
7 730
8 359
10 222
9 382
9 929
Additional Paid In Capital
244
1 771
1 544
1 476
1 930
1 991
2 321
1 530
1 439
958
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
141
5
Treasury Stock
0
0
0
0
87
100
195
251
106
106
Other Equity
2
2
3
16
48
2
25
32
70
83
Total Equity
4 838
N/A
7 469
+54%
7 964
+7%
8 655
+9%
10 534
+22%
11 132
+6%
11 972
+8%
12 981
+8%
12 426
-4%
12 368
0%
Total Liabilities & Equity
12 921
N/A
15 413
+19%
17 126
+11%
21 532
+26%
25 172
+17%
24 014
-5%
16 494
-31%
16 542
+0%
16 478
0%
16 714
+1%
Shares Outstanding
Common Shares Outstanding
1 446
1 513
1 513
1 513
1 513
1 513
1 513
1 499
1 494
1 494

See Also

Discover More